WallStSmart
RIGL

Rigel Pharmaceuticals Inc

NASDAQ: RIGL · HEALTHCARE · BIOTECHNOLOGY

$29.22
-4.38% today

Updated 2026-04-29

Market cap
$564.75M
P/E ratio
1.57
P/S ratio
1.92x
EPS (TTM)
$19.48
Dividend yield
52W range
$17 – $52
Volume
0.4M

Rigel Pharmaceuticals Inc (RIGL) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$33.47M$12.60M$750000.00$125.00M$4.75M$2.25M$7.15M$8.25M$28.89M$20.38M$4.48M$44.51M$59.29M$108.62M$149.24M$120.24M$116.88M$179.28M$294.28M
Revenue growth (YoY)-62.4%-100.0%+16566.7%-96.2%-52.6%+217.8%+15.4%+250.2%-29.5%-78.0%+892.6%+33.2%+83.2%+37.4%-19.4%-2.8%+53.4%+64.1%
Cost of revenue$75.10M$90.78M$1.43M$1.40M$88.37M$89.16M$99.19M$75.33M$67.70M$62.83M$63.45M$46.27M$287000.00$906000.00$895000.00$1.08M$1.75M$7.11M$18.65M$19.62M
Gross profit$33.47M$12.60M$750000.00$125.00M$4.75M$2.25M$-68.18M$-59.45M$-33.93M$-43.06M$-41.78M$44.22M$58.38M$107.73M$148.15M$118.49M$109.77M$160.63M$274.66M
Gross margin100.0%100.0%100.0%100.0%100.0%100.0%-953.5%-720.6%-117.4%-211.3%-931.9%99.4%98.5%99.2%99.3%98.5%93.9%89.6%93.3%
R&D$56.97M$70.36M$109.67M$90.74M$64.39M$69.35M$78.78M$75.33M$67.70M$62.83M$63.45M$46.27M$46.90M$52.88M$60.10M$65.24M$60.27M$24.52M$23.38M$33.30M
SG&A$19.55M$21.76M$27.04M$20.90M$25.29M$21.77M$22.85M$19.61M$31.80M$17.81M$20.91M$37.83M$70.00M$74.59M$76.60M$91.89M$112.45M$111.06M$113.06M$115.90M
Operating income$-43.05M$-79.53M$-136.71M$-112.04M$35.32M$-86.37M$-99.38M$-89.47M$-91.25M$-51.74M$-69.74M$-79.62M$-72.68M$-69.09M$-28.97M$-12.50M$-55.55M$-20.49M$24.19M$125.47M
Operating margin-128.6%-631.2%-14938.3%28.3%-1818.3%-4416.8%-1251.3%-1106.0%-179.1%-342.2%-1775.6%-163.3%-116.5%-26.7%-8.4%-46.2%-17.5%13.5%42.6%
EBITDA$-41.63M$-79.53M$-130.85M$-110.03M$39.30M$-83.99M$-96.94M$-85.20M$-88.89M$-50.30M$-63.03M$-77.53M$-72.09M$-65.88M$-27.68M$-11.29M$-53.87M$-16.98M$28.51M$127.88M
EBITDA margin-124.4%-631.2%-14671.2%31.4%-1768.3%-4308.6%-1191.6%-1077.5%-174.1%-309.2%-1729.0%-162.0%-111.1%-25.5%-7.6%-44.8%-14.5%15.9%43.5%
EBIT$-43.05M$-80.87M$-132.28M$-111.44M$37.98M$-85.95M$-99.38M$-87.79M$-91.25M$-51.74M$-63.97M$-77.99M$-72.68M$-66.56M$-28.39M$-12.45M$-54.87M$-18.22M$26.28M$125.47M
Interest expense$290000.00$221000.00$160000.00$203000.00$91000.00$25000.00$17000.00$16000.00$0.00$0.00$0.00$0.00$0.00$335000.00$1.35M$4.86M$3.71M$6.87M$7.92M$7.32M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-37.64M$-74.27M$-132.35M$-111.55M$37.89M$-85.97M$-98.84M$-89.03M$-90.91M$-51.46M$-69.22M$-77.99M$-70.48M$-66.55M$-29.74M$-17.91M$-58.57M$-25.09M$17.48M$367.02M
Net income growth (YoY)-97.3%-78.2%+15.7%+134.0%-326.9%-15.0%+9.9%-2.1%+43.4%-34.5%-12.7%+9.6%+5.6%+55.3%+39.8%-227.0%+57.2%+169.7%+1999.1%
Profit margin-112.4%-589.5%-14872.9%30.3%-1810.0%-4392.9%-1245.1%-1101.9%-178.1%-339.6%-1739.3%-158.3%-112.2%-27.4%-12.0%-48.7%-21.5%9.8%124.7%